Ivry-sur-Seine, France, 10 December 2025, 7h45FNAC DARTY ANNOUNCES FULL BUY-IN OF UK PENSION SCHEMEFnac Darty today announces that it has reached an agreement with the Trustee of the Comet Pension Scheme in the UK to fully insure the Scheme’s liabilities through a £330 million full buy-in with Canada Life UK.The transaction secures the long-term benefits of all Scheme members by transferring the financial risk associated with future pension payments to a highly rated insurer. This marks a major de-risking milestone for Fnac Darty, providing greater cost certainty and strengthening its
Amsterdam 10 December 2025 | The Magnum Ice Cream Company (TMICC; AEX: "MICC”), the world’s largest ice cream company, today confirmed its inclusion in the AEX Index on Euronext Amsterdam as of its first day of trading on 8 December. The announcement follows Euronext’s quarterly index review, which is based on criteria, including free-float and market capitalisation.The AEX Index comprises the 30 largest and most actively traded companies listed on Euronext Amsterdam and is the main index of the Dutch stock market."As the global ice cream leader, headquartered in Amsterdam, The
Sampo plc, stock exchange release, 10 December 2025 at 8:30 am EETSampo plc’s share buybacks 9 December 2025On 9 December 2025, Sampo plc (business code 0142213-3, LEI 743700UF3RL386WIDA22) has acquired its own A shares (ISIN code FI4000552500) as follows: Sampo plc’s share buybacksAggregated daily volume (in number of shares)Daily weighted average price of the purchased shares*Market (MIC Code) 9,99010.04AQEU 111,76210.04CEUX 36,07110.04TQEX 102,33210.04XHELTOTAL260,15510.04 * rounded to two decimals On 5
Paris, France - December 10, 2025Viridien has announced a new multi-client seismic reimaging program over Angola’s highly prospective offshore block 22 to support the country’s upcoming licensing round. The 4,300 sq km high-end data set will bring valuable insight into underexplored structures along the Atlantic Hinge zone, following the same trend as the proven Cameia and Golfinho fields. Fast-track results are scheduled for delivery in Q1 2026 and final products in Q3/Q4 2026.Viridien will reimage the block 22 data set with its latest proven proprietary technologies, including time-lag
Dubai, Dec. 10, 2025 (GLOBE NEWSWIRE) --Collaboration will deliver stablecoin‑based FX, CBDC‑ready rails, and compliant, mobile‑first user experiencesPartnership will support African governments and central banks with permissioned, compliance‑first CBDC sub‑networksThe partnership will reduce settlement times from days to secondsDubai, United Arab Emirates, December 10, 2025 - Global Settlement Holdings Inc. (also known as Global Settlement Network and GSX) today announced a strategic partnership with Ubuntu Tribe to enable the tokenization of gold and other real‑world assets,
Press release - Regulated InformationIeper, Belgium - 10 December 2025, 07.00 hrs CET - Melexis NV (Euronext Brussels: MELE) ("Melexis”) announces a new share buy-back program.The share buy-back program initiated by Melexis NV on 11 December 2024 will expire today 10 December 2025.Melexis’ Board of Directors has decided to initiate a new share buy-back program of its outstanding common stock for up to an additional 850,000 shares for an amount of up to EUR 50 million. This follows the shareholders’ authorization granted in November 2023. The share buy-back program is scheduled to run
(2025-12-10) Kitron is hosting a Capital Markets Presentation today to update investors on the company's financial and commercial targets and ambitions.Reflecting accelerating defence demand and expanded capacity, Kitron is updating and extending its medium-term ambitions. Over the coming year, the company expects to approach its previously communicated revenue target of EUR 1 billion. Kitron now outlines the way forward to EUR 1.5 billion in revenue.Kitron’s strategy calls for this growth to be combined with an EBIT margin above 9 per cent and a return on operating capital above 25
Strategic highlights: Aegon announces ambition to become a leading US life insurance and retirement group Aegon to move its head office and legal seat to the US and be renamed Transamerica Inc. at completion of transition, which Aegon aims to conclude by January 1, 2028Aegon Asset Management to focus on growing third-party revenues and improving efficiencyContinued focus on profitable growth in Aegon’s International business Strategic review of Aegon UK, evaluating all options, including divestmentFinancial highlights:Achieving all financial targets for 2025Further execution upon Aegon’s
Coop Pank’s financial results in November 2025:In November, the number of the bank’s customers increased by 1,800 and number of active customers increased by 1,000. By the end of the month number of customers reached 225,800 and number of active customers reached 107,800. Over the year, customer base has grown by 10%.Volume of the bank's customer deposits increased by 24 million euros and reached 1.97 billion euros by the end of the month. Deposits of corporate customers increased by 22 million euros and deposits of private customers increased by 11 million euros. The volume of
LONDON, 10 Dec. 2025 (GLOBE NEWSWIRE) -- This is the Start of Day Message for GlobeNewswire.GlobeNewswire is operated by Notified and is designated by the FCA as an approved primary information provider.DisclaimerThe content and accuracy of all information distributed through Notified is wholly the responsibility of the originator. Notified accepts no liability for any losses arising from reliance by any person upon the content of any announcement.If you have any questions about this message, please Contact Us.
New analysis from landmark Phase 3 PRECISION trial published in Hypertension highlights the renal-protective benefits of aprocitentan in addition to the marked reduction in blood pressure in a high-risk CKD population with difficult-to-control hypertensionAllschwil, Switzerland - December 10, 2025Idorsia Ltd (SIX: IDIA) announced the publication of a new analysis from the landmark Phase 3 PRECISION study in Hypertension titled "Aprocitentan in Patients with Chronic Kidney Disease and Resistant Hypertension”.1 The analysis examined the efficacy and safety of aprocitentan
(10 December 2025 - Oslo, Norway) Reference is made to the stock exchange release by Hexagon Purus ("the "Company”) on 18 April 2023 and 25 October 2024, where Hexagon Purus Systems USA LLC, a subsidiary of the Company, signed a multi-year agreement for the supply of lithium-ion battery cells and the subsequent amendment of its terms.Hexagon Purus Systems USA LLC has today entered into a second amendment to the supply agreement with its battery cell supplier. Under this amended agreement, the previously outstanding pre-payment obligation of USD 12.9 million is removed in full, while
SOUTH SAN FRANCISCO, Calif., Dec. 10, 2025 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ: DNLI) today announced the pricing of its underwritten public offering of 9,142,857 shares of its common stock at a price to the public of $17.50 per share and, in lieu of common stock to certain investors, pre-funded warrants to purchase 2,285,714 shares of common stock at a price of $17.49 per pre-funded warrant, which represents the per share public offering price of each share of common stock less the $0.01 per share exercise price for each pre-funded warrant. All of the shares and pre-funded
CALGARY, Alberta, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Canacol Energy Ltd. (TSX: CNE) (OTCID: CNNEQ) (BVC: CNEC) ("Canacol” or the "Company”) announces that it has entered into an agreement with an ad hoc group of holders of the Company’s 5.75% senior unsecured notes due 2028 (the "DIP Credit Agreement”) for debtor-in-possession financing (the "DIP Financing”), comprised of a U.S.$45 million delayed-draw new-money term loan (the "Term Loan Tranche”) with capacity to obtain additional commitments to issue up to U.S.$22 million in letters of credit to renew and/or replace certain
FOSTER CITY, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. ("Terns” or the "Company”) (Nasdaq: TERN), a clinical-stage oncology company, today announced the pricing of its upsized underwritten public offering of 16,250,000 shares of its common stock at a public offering price of $40.00 per share, before underwriting discounts and commissions. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Terns, are expected to be $650 million, excluding any exercise of the underwriters’ option
WATERTOWN, Mass., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, today announced the pricing of its underwritten public offering of $602.0 million of shares of its common stock. Kymera is selling 7,000,000 shares of common stock in the offering, which are being sold at a public offering price of $86.00 per share. In addition, Kymera has granted the underwriters a 30-day option to purchase up to an additional 1,050,000 shares of its
SAN FRANCISCO, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, with a focus on obesity, today announced the pricing of its upsized underwritten public offering of 8,461,538 American depositary shares (ADSs), each representing three ordinary shares, at a price to the public of $65.00 per ADS and pre-funded warrants to purchase 1,538,462 ADSs at a price to the public of $64.9999 per pre-funded warrant. All of the securities in the offering are
SINGAPORE, Dec. 09, 2025 (GLOBE NEWSWIRE) -- ChemOne Group ("ChemOne”) is pleased to announce the appointment of Dato’ Sri Mohamed Nazri Abdul Aziz as a Board Member of Pengerang Energy Complex Sdn Bhd ("PEC”) and Advisor to the Group, further enhancing ChemOne’s leadership capabilities and strategic direction.Dato’ Sri Nazri, a prominent Malaysian statesman, formerly served as a Minister in the Prime Minister’s Office, holding several key national portfolios, and most recently as Malaysia’s Ambassador to the United States. His extensive experience in international relations,
This production start follows the recent arrival of multiple full sets of knockdown components - nearly 3,000 parts per vehicle - required for building the first batch of complete pre-production FX Super One vehicles which, once assembled, will be used for testing, marketing and other planning activities in the U.S.This production milestone marks the second vehicle model to come out of the Hanford facility, named "FF aiFactory California," along with the Company’s FF 91 2.0 that is also assembled there. LOS ANGELES, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Faraday Future Intelligent Electric Inc.
CAMBRIDGE, Mass., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health ("Wave” or "Wave Life Sciences”), announced today the pricing of its previously announced underwritten public offering of 15,789,475 of its ordinary shares at a price to the public of $19.00 per ordinary share, and, in lieu of ordinary shares to certain investors, pre-funded warrants to purchase up to 2,631,578 ordinary shares at an offering price of $18.9999 per pre-funded
